31 completed, 16 unknown, 12 active not recruiting, 12 recruiting. 24 Phase 2, 20 Not applicable, 7 Phase 3, 5 Early Phase 1, 2 Phase 1.
Follow Invasive Breast Cancer: new trials by email Literature Review of Invasive Breast Cancer trials Research Report on Invasive Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy Blood and tumor tissue collection - Invasive Breast Cancer | Recruiting | Istituti Clinici Scientifici Maugeri SpA | 240 | 2025-09-23 | 2025-12-03 | |
| Evaluation of the RESTART Survival Programme educational workshops - Invasive Breast Cancer | Not yet recruiting | Jules Bordet Institute | 200 | 2025-03-01 | 2025-02-28 | |
| Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01) Blood and tumor tissue collection - Invasive Breast Cancer | Active not recruiting | Istituti Clinici Scientifici Maugeri SpA | 50 | 2025-01-01 | 2026-02-19 | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy Chemoradiation - Invasive Breast Cancer, Stage III Breast Cancer | Phase 3 | Recruiting | Dr. Tabassum Wadasadawala | 858 | 2024-05-14 | 2025-04-13 |
| Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma no intervention - Invasive Breast Cancer | Unknown | Marwa Mahmoud Hassan | 70 | 2024-03-19 | 2024-04-10 | |
| Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer Preoperative PBI - Breast Cancer, Ductal Carcinoma in Situ | Phase 2 | Recruiting | Yonsei University | 47 | 2023-10-13 | 2024-11-07 |
| Fulvestrant + Neratinib In Breast Cancer NERATINIB, FULVESTRANT - Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer | Phase 2 | Withdrawn | Massachusetts General Hospital | 2023-07-01 | 2023-08-01 | |
| TRUDI: TDXD+Durva in HER2+/Low IBC Trastuzumab deruxtecan, Durvalumab - Invasive Breast Cancer, Inflammatory Breast Cancer Stage III | Phase 2 | Recruiting | Filipa Lynce, MD | 63 | 2023-05-04 | 2026-10-09 |
| Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer Invasive Breast Cancer | Unknown | Peking University | 60 | 2023-03-06 | 2023-03-14 | |
| (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer (Z)-endoxifen, goserelin - Breast Neoplasms, Invasive Breast Cancer | Phase 2 | Active not recruiting | Atossa Therapeutics, Inc. | 87 | 2023-02-14 | 2026-07-08 |
| EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast Invasive Breast Cancer | Unknown | Sohag University | 40 | 2023-01-01 | 2023-01-31 | |
| Onvansertib + Paclitaxel In TNBC Onvansertib, Paclitaxel - Breast Cancer, Invasive Breast Cancer | Phase 1 / Phase 2 | Active not recruiting | Antonio Giordano, MD | 50 | 2022-09-30 | 2026-02-11 |
| Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer ultrasound combined with microbubbles - Invasive Breast Cancer, Cavitation | Unknown | Beijing Friendship Hospital | 30 | 2022-09-29 | 2023-12-06 | |
| A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer Pre-neoadjuvant radiotherapy (NART) biopsy, Neoadjuvant radiotherapy, Unilateral total mastectomy with axillary lymph node dissection - Breast Cancer, Invasive Breast Cancer | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2022-06-06 | 2026-09-24 |
| Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients Standard of Care Neoadjuvant Chemotherapy (NAC), Vitamin D3, Drug Diary - Triple Negative Breast Cancer, Vitamin D Deficiency | Phase 2 | Recruiting | Wake Forest University Health Sciences | 50 | 2021-10-22 | 2026-08-28 |
| CONFIRM: Magnetic Resonance Guided Radiation Therapy Viewray MRIdian® Linac - Gastric Cancer, Invasive Breast Cancer | Not applicable | Recruiting | Brigham and Women's Hospital | 70 | 2021-05-01 | 2026-02-09 |
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. Hypofractionated radiotherapy - Ductal Breast Carcinoma in Situ, Invasive Breast Cancer | Not applicable | Active not recruiting | Coordinación de Investigación en Salud, Mexico | 72 | 2021-04-26 | 2026-03-23 |
| Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer Radiotherapy - Invasive Breast Cancer, Post-mastectomy | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 71 | 2020-11-24 | 2026-05-26 |
| Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer Anastrozole, Therapeutic Conventional Surgery, Trastuzumab Deruxtecan - Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 88 | 2020-10-09 | 2025-11-10 |
Showing 20 of 81. Sign in to see all of them.
Breast Neoplasms (42) · Carcinoma, Intraductal, Noninfiltrating (9) · Triple Negative Breast Neoplasms (8) · Breast Carcinoma In Situ (5) · Carcinoma, Ductal, Breast (2) · Inflammatory Breast Neoplasms (2) · Ovarian Neoplasms (2) · Arthralgia (1) · Breast Diseases (1) · Breast Neoplasms, Male (1) · Carcinoma (1) · Carcinoma, Lobular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Cancer, Hereditary Nonpolyposis, Type 8 (1) · Fanconi Anemia, Complementation Group D1 (1)
Neoplasms (53) · Skin Diseases (51) · Skin and Connective Tissue Diseases (51) · Breast Diseases (50) · Neoplasms by Site (50) · Neoplasms by Histologic Type (17) · Neoplasms, Glandular and Epithelial (17) · Carcinoma (16) · Carcinoma in Situ (13) · Adenocarcinoma (12) · Neoplasms, Ductal, Lobular, and Medullary (12) · Breast Neoplasms (9) · Breast Carcinoma In Situ (8) · Pathological Conditions, Signs and Symptoms (4) · Female Urogenital Diseases (3)
Cyclophosphamide (5) · Paclitaxel (5) · Anastrozole (4) · Doxorubicin (4) · Blood Specimen Collection (3) · Carboplatin (3) · Fulvestrant (2) · Letrozole (2) · Neoadjuvant Therapy (2) · Surgical Procedures, Operative (2) · Tamoxifen (2) · Trastuzumab (2) · atezolizumab (2) · liposomal doxorubicin (2) · pembrolizumab (2)
Memorial Sloan Kettering Cancer Center (4) · Peking University (4) · Massachusetts General Hospital (3) · Medical College of Wisconsin (3) · Brigham and Women's Hospital (2) · Case Comprehensive Cancer Center (2) · Institut Cancerologie de l'Ouest (2) · Istituti Clinici Scientifici Maugeri SpA (2) · Jules Bordet Institute (2) · Seoul National University Hospital (2) · Wake Forest University Health Sciences (2) · Aarhus University Hospital (1) · Alpha Tau Medical LTD. (1) · Ana C Garrido-Castro, MD (1) · Antonio Giordano, MD (1)
United States (41) · Canada (7) · China (6) · France (4) · Italy (4) · South Korea (4) · United Kingdom (2) · Austria (1) · Belgium (1) · Denmark (1) · Egypt (1) · Germany (1) · Hungary (1) · India (1) · Mexico (1)
Adam Currey, MD, PhD (1) · Aditya Bardia, MD,MPH (1) · Afaf Alnashar, professor (1) · Aftif Khan, MD (1) · Akos Savolt, M.D. (1) · Aleksandr Obukhov (1) · Amanda Toland, PhD (1) · Amy Fowler, MD, PhD (1) · Ana Garrido-Castro, MD (1) · Angel Arnaout, MD (1) · Angus Lau, PhD (1) · Antonio C Giordano, MD, PhD (1) · Chirag Shah, MD (1) · Chuanmiao Xie, PhD (1) · Colleen Bailey, PhD (1)
PMID 14575828, PMID 20570343, PMID 22298678, PMID 22791786, PMID 23110817, PMID 23990869, PMID 24224997, PMID 25452445, PMID 26178760, PMID 26991020, PMID 27588192, PMID 27689969, PMID 30225621, PMID 30463611, PMID 30877499, PMID 31449469, PMID 31833973, PMID 32239210, PMID 32816842, PMID 33119476, PMID 34035435, PMID 35616948, PMID 36028065, PMID 36944848, PMID 37103597, PMID 37460683, PMID 37791898, PMID 38092228, PMID 38095878, PMID 38858721, PMID 40097486, PMID 41525075, PMID 41604601, PMID 41656585, PMID 41898311
P30CA012197 (2), 1UL1TR002373-01 (1), 2009 (1), 2017 (1), 4UL1TR000427-10 (1), P50CA058223 (1)